NCT06604793 Creatine Supplementation in Young Healthy Adults
| NCT ID | NCT06604793 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Regina |
| Condition | Improve Muscle Performance in Young Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2025-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2024-08-20 with a primary completion date of 2025-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose is to compare the effects of bolus ingestion (5 grams) vs. intermittent ingestion (2 x 2.5 grams) of creatine supplementation vs. placebo for 21 days on measures of body composition (lean tissue mass-indicator of muscle mass, total body water) and muscle performance (i.e., power, strength, endurance).
Eligibility Criteria
Inclusion Criteria: * if you are 18-39 years of age * if you have not been performing resistance training for at least 4 weeks prior to the start of the study. Exclusion Criteria: * if you are pregnant or nursing * have taken creatine monohydrate within 30 days prior to the start of the study * if you have pre-existing allergies to the placebo (corn-starch maltodextrin)
Contact & Investigator
Darren Candow
PRINCIPAL INVESTIGATOR
University of Regina
Frequently Asked Questions
Who can join the NCT06604793 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 39 Years, studying Improve Muscle Performance in Young Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06604793 currently recruiting?
Yes, NCT06604793 is actively recruiting participants. Contact the research team at Darren.Candow@uregina.ca for enrollment information.
Where is the NCT06604793 trial being conducted?
This trial is being conducted at Regina, Canada.
Who is sponsoring the NCT06604793 clinical trial?
NCT06604793 is sponsored by University of Regina. The principal investigator is Darren Candow at University of Regina. The trial plans to enroll 42 participants.